Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Tamblin
Institution:
University at Buffalo, State University of New York
Observed institution:
University at Buffalo, State University of New York
OpenAlex ID:
A5092021331
An immunoregulator nanomedicine approach for the treatment of tuberculosis
2023
·
Luona Yang
, Lee Chaves
, et al.
·
Frontiers in Bioengineering and Biotechnology
·
11
PDF
Inhalational Delivery of β‐glucan‐chitosan‐poly(lactic co‐glycolic) acid Nanoparticles Enhance Alveolar Macrophage Rifampin Concentrations for the Treatment of Tuberculosis
2024
·
Hilliard L. Kutscher
, Maria Tamblin
, et al.
·
Advanced Therapeutics
·
8
PDF
Repeated pulmonary dosing of β-glucan-chitosan-PLGA nanoparticles controls Mycobacterium tuberculosis in mice
2026
·
Hilliard L. Kutscher
, Maria Tamblin
, et al.
·
Antimicrobial Agents and Chemotherapy
·
5
Weekly pulmonary delivery of β-glucan-chitosan-poly(lactic co-glycolic) acid (β-C-P) nanoparticles with daily standard oral therapy achieves control of Mycobacterium tuberculosis in BALB/c mice
2026
·
Hilliard L. Kutscher
, Maria Tamblin
, et al.
·
Antimicrobial Agents and Chemotherapy
Determining the minimum inhibitory concentrations of pyrazinamide against Mycobacterium tuberculosis clinical isolates at a neutral pH of 6.8 using the broth microdilution method
2025
·
Maria Tamblin
, Wanliang Shi
, et al.
·
Frontiers in Microbiology
PDF
Show more works
View as search
Works count:
5
Citation count:
24
H-index:
3
I10-index:
1
Year
Topic
Type